Early infant diagnosis
30 December 2009. Related: Conference reports, Paediatric care.
Conference reports
Difficulties with implementation
30 December 2009. Related: Conference reports, Paediatric care.
Infant outcomes
30 December 2009. Related: Conference reports, Paediatric care.
Improved neurodevelopmental outcomes
30 December 2009. Related: Conference reports, Paediatric care.
Treating children exposed to single dose nevirapine for PMTCT
30 December 2009. Related: Conference reports, Paediatric care.
Using a nevirapine-containing fixed dose combination in the CHAPAS trial
30 December 2009. Related: Conference reports, Paediatric care.
Once a day lamivudine and abacavir, and abacavir hypersensitivity in the ARROW trial
30 December 2009. Related: Conference reports, Paediatric care.
5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 19-23 July 2009, Cape Town
5 October 2009. Related: Conference reports.
First results of new integrase compound: GSK1349572
5 October 2009. Related: Conference reports, Antiretrovirals.
Raltegravir in treatment-naive patients
5 October 2009. Related: Conference reports, Antiretrovirals.
Nevirapine vs atazanavir/ritonavir in treatment-naive patients: ARTEN study
5 October 2009. Related: Conference reports, Antiretrovirals.
Darunavir/r monotherapy studies
5 October 2009. Related: Conference reports, Antiretrovirals.
Maraviroc results similar to efavirenz when analysed using more sensitive tropism test
5 October 2009. Related: Conference reports, Antiretrovirals.
Lipid and metabolic changes with ARV combinations
5 October 2009. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
Maximal suppression achieved with three drugs: no additional virological impact of raltegravir intensification
5 October 2009. Related: Conference reports, Antiretrovirals.
Tenofovir and renal safety
5 October 2009. Related: Conference reports, Side effects.
Time from seroconversion to treatment in Europe and Africa
5 October 2009. Related: Conference reports.
Pharmacokinetics of atazanavir/ritonavir during pregnancy
5 October 2009. Related: Conference reports, Pregnancy.
Presentation with late stage HIV in women diagnosed during pregnancy
5 October 2009. Related: Conference reports, Pregnancy.
Low transmission rates and favourable pregnancy outcomes reported in the DREAM study
5 October 2009. Related: Conference reports, Pregnancy.
Pregnancy rates and outcomes among women in the DART trial
5 October 2009. Related: Conference reports, Pregnancy.
Pregnancy outcomes in HAART exposed infants in Johannesburg
5 October 2009. Related: Conference reports, Paediatric care.
Efavirenz conceptions in Soweto
5 October 2009. Related: Conference reports, Pregnancy.
Impact of regimen and duration of therapy on risk of mother-to-child HIV transmission in Johannesburg
5 October 2009. Related: Conference reports, Pregnancy.
A cost-effectiveness analysis of the OCTANE trial
5 October 2009. Related: Conference reports, Pregnancy.
The PEARL study
5 October 2009. Related: Conference reports, Pregnancy.
Results from HSV-2 acyclovir studies
5 October 2009. Related: Conference reports.
Overview of TB-related studies at IAS
5 October 2009. Related: Conference reports, TB coinfection.
5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 19-23 July 2009, Cape Town
23 August 2009. Related: Conference reports.
Five-year survival rates of 87% without routine CD4 or laboratory monitoring in DART study demonstrate an important model for ARV access programmes
23 August 2009. Related: Conference reports, Treatment access.
Biomarkers associated with mortality: long-term follow up from SMART
23 August 2009. Related: Conference reports.
Update on Interleukin-2 clinical trials
23 August 2009. Related: Conference reports.
Influenza vaccine effective in HIV-positive adults
23 August 2009. Related: Conference reports.
Reducing HIV transmission during breastfeeding
23 August 2009. Related: Conference reports, Pregnancy.
Treating children previously exposed to single dose nevirapine
23 August 2009. Related: Conference reports, Paediatric care.
10th International Workshop on Clinical Pharmacology of HIV Therapy, 15-17 April 2009, Amsterdam
23 August 2009. Related: Conference reports.
Monotherapy study may explain previous poor clinical results when abacavir and tenofovir are used in combination
23 August 2009. Related: Conference reports, PK and drug interactions.
Interactions between ARVs and antimalarials atovaquone and proguanil
23 August 2009. Related: Conference reports, PK and drug interactions.
Four weeks lopinavir/r to cover functional monotherapy when stopping HAART
23 August 2009. Related: Conference reports, Antiretrovirals.
Efavirenz-related studies: genetics, smoking and TDM
23 August 2009. Related: Conference reports, Antiretrovirals.
Atazanavir: a suitable case for TDM?
23 August 2009. Related: Conference reports, Antiretrovirals.
Raltegravir PK in blood plasma and the genital tract
23 August 2009. Related: Conference reports.
A CYP2B6 haplotype influences nevirapine plasma concentrations following a single dose to reduce mother to child transmission
23 August 2009. Related: Conference reports, Pregnancy.
Population pharmacokinetic model of nevirapine maternal to infant transfer through breastfeeding
23 August 2009. Related: Conference reports, Paediatric care.
Phenotypic and genotypic inhibitory quotients and virologic response in treatment experienced children
23 August 2009. Related: Conference reports, Paediatric care.
Tenofovir pharmacokinetics in three tenofovir-containing regimens in children and adolescents
23 August 2009. Related: Conference reports, Paediatric care.
Bioavailability of Thai generic lopinavir/ritonavir
23 August 2009. Related: Conference reports.
XVIII International Drug Resistance Workshop, 9-13 June 2009, Florida
22 August 2009. Related: Conference reports.
Transmitted multidrug-resistant HIV persists in PBMC DNA for years
22 August 2009. Related: Conference reports, Drug resistance.
Low-level Q148R in people without integrase inhibitor experience
22 August 2009. Related: Conference reports, Drug resistance.
Cut-offs suggested for predicting efavirenz failure with low-level K103N
22 August 2009. Related: Conference reports, Drug resistance.
Lower M184V rates with FTC/TDF than with 3TC/TDF
22 August 2009. Related: Conference reports, Drug resistance.
HBV resistance to lamivudine at undetectable and low levels of viremia
22 August 2009. Related: Conference reports, Hepatitis coinfection, Drug resistance.
15th Annual Conference of the British HIV Association (BHIVA), 1-3 April 2009, Liverpool
8 June 2009. Related: Conference reports.
Superinfection identified in 2 out of 8 patients with unexpected viral load increases
8 June 2009. Related: Conference reports.
Peripheral DEXA scans to identify rates of reduced bone mineral density
8 June 2009. Related: Conference reports.
Vitamin D deficiency, supplementation and tenofovir
8 June 2009. Related: Conference reports.
High rate of lost and untested TB biopsy samples and low screening for latent TB
8 June 2009. Related: Conference reports, TB coinfection.
16th Conference on Retroviruses and Opportunistic Infections (CROI), 8-11 February 2009, Montreal
8 June 2009. Related: Conference reports.
Assessing the cardiovascular impact of HIV, abacavir, and new signals for lopinavir/r
3 June 2009. Related: Conference reports, Side effects.
Intensive smoking cessation programme reports limited success at 6 months
3 June 2009. Related: Conference reports, Side effects.
HDL particle concentration predicts cardiovascular disease in SMART
3 June 2009. Related: Conference reports, Side effects.
No effect of hormonal contraception on HIV disease progression in large multi-country cohort
3 June 2009. Related: Conference reports, Women's health.
Pregnancy, family planning, and HIV acquisition in HPTN 039
3 June 2009. Related: Conference reports, Pregnancy.
Progression and regression of pre-malignant cervical lesions in HIV-positive women from Soweto
3 June 2009. Related: Conference reports.